| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 4 1496-1502, Copyright © 1993 by American Association of Immunologists
ARTICLES |
JA Hamilton, PM Waring and EL Filonzi
University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.
The cytokines, IL-1 alpha and TNF-alpha, induced a dose-dependent production of leukemia inhibitory factor (LIF) in cultured human synovial fibroblast-like cells, as measured by a radioreceptor competition assay. Significant levels of LIF were first detected in cell supernatants between 2 and 4 h after cytokine addition. Increases were also observed in LIF mRNA steady-state expression. Evidence is presented for down-regulation of the IL-1-induced LIF activity by an endogenous cyclo-oxygenase product(s); the glucocorticoid, dexamethasone, lowered the IL-1-induced LIF activity and mRNA expression. A synergistic effect was noted between the actions of IL-1 alpha and TNF-alpha, and between IL-1 and transforming growth factor- beta. IFN-gamma could not induce LIF formation in the synovial cells but inhibited the stimulatory effect of IL-1. These results suggest that cytokine-stimulated synovial fibroblasts may be a major source of intraarticular LIF production in the joints of patients with inflammatory arthritis. Synoviocyte-derived LIF may activate monocyte/macrophages in the lesions and may contribute to the bone changes and certain systemic manifestations in patients with inflammatory joint disease.
This article has been cited by other articles:
|
|
 |
|
  I. V Mikhaylova, T. Jaaskelainen, J. Jaaskelainen, J. J Palvimo, and R. Voutilainen Leukemia inhibitory factor as a regulator of steroidogenesis in human NCI-H295R adrenocortical cells J. Endocrinol., December 1, 2008; 199(3): 435 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Palmqvist, P. Lundberg, I. Lundgren, L. Hanstrom, and U.H. Lerner IL-1{beta} and TNF-{alpha} Regulate IL-6-type Cytokines in Gingival Fibroblasts Journal of Dental Research, June 1, 2008; 87(6): 558 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Trial, R. D. Rossen, J. Rubio, and A. A. Knowlton Inflammation and Ischemia: Macrophages Activated by Fibronectin Fragments Enhance the Survival of Injured Cardiac Myocytes Experimental Biology and Medicine, June 1, 2004; 229(6): 538 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Auernhammer and S. Melmed Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function Endocr. Rev., June 1, 2000; 21(3): 313 - 345. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. G. Ren, J. Seliktar, X. Li, J. M. Hershman, G. D. Braunstein, and S. Melmed In Vivo and in Vitro Regulation of Thyroid Leukemia Inhibitory Factor (LIF): Marker of Hypothyroidism J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2883 - 2887. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. A. Gadient and P. H. Patterson Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and Injury Stem Cells, May 1, 1999; 17(3): 127 - 137. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. J. Auernhammer, V. Chesnokova, and S. Melmed Leukemia Inhibitory Factor Modulates Interleukin-1{beta}-Induced Activation of the Hypothalamo-Pituitary-Adrenal Axis Endocrinology, May 1, 1998; 139(5): 2201 - 2208. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
